Kayani Kayani (@kayani1995) 's Twitter Profile
Kayani Kayani

@kayani1995

Birmingham NIHR ACF/ST2 in General Surgery, West Mids Research Collab Associate PI Aspiring transplant surgeon, Loves Livers, Proud to call @mohammadkayani3 dad

ID: 232600878

calendar_today31-12-2010 16:52:55

257 Tweet

347 Takipçi

1,1K Takip Edilen

Oo Lab (@liverimmunoreg1) 's Twitter Profile Photo

More of our members are presenting posters at #BSI23 today! Amber Bozward is P-406 and shows our work on TIGIT+ Tregs in #AIH Dr Scott P Davies is P-426 which discusses our work on CD8+ T cell cell-in-cell structures in the liver. BSI Congress & Events.

Kayani Kayani (@kayani1995) 's Twitter Profile Photo

An incredible talk from Christopher Buckley BSI Congress & Events proposing the need for a comprehensive human cell atlas, a greater appreciation of cells and their complex interactions and an appreciation that common inflammatory processes are across disease types #BSI23

The Herrick Society (@herricksociety) 's Twitter Profile Photo

"🎄🎓 Get into the festive spirit with our Transplant Teaching Quiz! 🏆 Join us for a fun, light-hearted session and you might just snag the top prize! Save the date: 🗓️ Dec 12th, 5:30 PM GMT. Click the banner for the joining details #TransplantQuiz2023

Dr Scott P Davies (@scottpland) 's Twitter Profile Photo

🚨NEW PAPER!! It gives me great pleasure to say that our latest publication is now out in Nature Communications! 🥳🥳 Here we report a new form of #cellincell structure in which #CD8 T cells can express E-cadherin and invade biliary epithelial cells! Link here! rdcu.be/dxcYC.

BTPT (@btptsociety) 's Twitter Profile Photo

Trainee/student coming to #BTS2024 today and don't have any plans this evening after the Welcome Reception? Join us & The Herrick Society at Major Tom's Social from 7.30pm (food available to order), just a few minutes walk (meet us there or join to leave from Congress together)

The Herrick Society (@herricksociety) 's Twitter Profile Photo

🌟 Huge congrats to the Clinical Surgery team for their exceptional efforts on CRAFT, achieving the first unit with 100% data collection! A golden star to Katie Katie Connor and team!! 👏 Royal Free London and Cambridge Transplant are right on their heels with fantastic progress! Go CRAFT Team🌟

Tom Whipple (@whippletom) 's Twitter Profile Photo

38 years ago a woman in Coventry sent a letter to some scientists. That letter went on to be the most important in Alzheimer's research. Last year, I met Carol Jennings, who wrote it. 1/ thetimes.co.uk/article/e78c47…

38 years ago a woman in Coventry sent a letter to some scientists. That letter went on to be the most important in Alzheimer's research. Last year, I met Carol Jennings, who wrote it. 1/

thetimes.co.uk/article/e78c47…
Andrew Beggs (@adbeggs) 's Twitter Profile Photo

Really exciting news this morning that my oncology colleague Dr Vicky Kunene University Hospitals Birmingham dosed the first patient in the BioNTech BNT-122 mRNA vaccine trial for personalised therapy in colorectal cancer - UHB Research was the first site in UK to do this: bbc.co.uk/news/articles/…

Immunology and Immunotherapy (@immunologyuob) 's Twitter Profile Photo

We loved seeing representation from our Oo Lab lab at the #EASLcongress in Milan this year! Such a wide breadth of #Liver research that helped to make the event a resounding success 👏 Next stop - Amsterdam 2025! 🚀 @unibirm_MDS

Ruth Millington (@ruth_millington) 's Twitter Profile Photo

As the Zephaniah family have said, this exhibition "depicts the many faces of Benjamin: the activist, the poet and author, the actor, the humanitarian, the voice of the marginalised and disenfranchised, and family man". Please visit if you can! bbc.com/news/articles/…

Andrew Beggs (@adbeggs) 's Twitter Profile Photo

Excited to show our latest attempt at a clinically meaningful clinical cancer genome with rapid turn around (24 hours!) times using Oxford Nanopore sequencing technology for patients who need a rapid, whole genome assessment of their tumour and germline, offering them (1/n):

Excited to show our latest attempt at a clinically meaningful clinical cancer genome with rapid turn around (24 hours!) times using Oxford Nanopore sequencing technology for patients who need a rapid, whole genome assessment of their tumour and germline, offering them (1/n):
Adnan Sharif (@adnansharif1979) 's Twitter Profile Photo

Important Kidney Care UK report highlights the importance for Department of Health and Social Care to champion equity of access to transplantation. Too many unnecessary obstacles ⛔️ and variation of practice 🤷🏽 that creates a postcode lottery for people with kidney failure. kidneycareuk.org/news-from-kidn…

Etowah Adams (@etowah0) 's Twitter Profile Photo

Molecular cloning: a ubiquitous and essential molecular biology technique. It's also the reason many scientists become superstitious, some equating cloning to witchcraft. But why, and does it have to be this way?

Molecular cloning: a ubiquitous and essential molecular biology technique. 

It's also the reason many scientists become superstitious, some equating cloning to witchcraft. 

But why, and does it have to be this way?
Shaun Lintern (@shaunlintern) 's Twitter Profile Photo

"We see the proportion of consultants who are academically qualified is going down, and the proportion of consultants that can do research is going down. It’s a big concern for UK faculties of medicine that it’s harder to get clinical academics" - John-Arne Røttingen Wellcome

Immune Regulation News (@immune_news) 's Twitter Profile Photo

🥼 Scientists found that Ikzf1 associated with Foxp3 via its exon 5 (IkE5) and that IkE5-deficient #Treg cells highly expressed 🧬 genes that would otherwise be repressed by Foxp3 upon T cell receptor stimulation, including Ifng. Immunity | bit.ly/4fKGLWm

🥼 Scientists found that Ikzf1 associated with Foxp3 via its exon 5 (IkE5) and that IkE5-deficient #Treg cells highly expressed 🧬 genes that would otherwise be repressed by Foxp3 upon T cell receptor stimulation, including Ifng.

<a href="/ImmunityCP/">Immunity</a> | bit.ly/4fKGLWm